Cavity foci in bone trabeculae, similar conditions in overweight and metabolic syndrome, and prevention or treatment of atypical osteoporosis associated with normal or abnormal bone tissue mineralization

摘要

Atypical osteoporosis prophylaxis and treatment with causal lesion occurrence in bone trabeculae, similar conditions in overweight and metabolic syndrome, and normal or abnormal bone tissue calcification. The agent belongs to the medical field, particularly the therapeutic and prophylactic drug field for various osteoporosis-related conditions such as metabolic syndrome. This prophylaxis and treatment method is a bee that is absorbed into the body at the same time within a day, daily usage: 10-1000 mg, and vitamin D system and / or its effective metabolites, daily usage: 50 -The administration of 100,000 ME, and the medicinal product containing 10-1000 milligrams of bees and vitamin D and / or its effective metabolite 50-100,000 ME is either powder, tablet or capsule. Is a feature. The technical results expected by the applicant during the introduction of the present invention (internal calcium redistribution (ie, reduction of calcification of soft tissues, blood vessels, organs, etc.) and creation of pharmaceuticals that promote columnar bone cavity filling) Achievement is ensured.